ARTICLE | Clinical News
PX-12: Began Phase I testing
October 1, 2001 7:00 AM UTC
ProlX Pharmaceuticals LP, Pittsburgh, Penn. Product: PX-12 Business: Cancer Therapeutic category: Cell proliferation Target: Thioredoxin Description: Small molecule inhibitor of thioredoxin cell grow...